SD

Shakuntala Devi

Active Director Director DIN 11215751
DIN 11215751 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shakuntala Devi

Data last updated:

Shakuntala Devi is a Director at Quinser Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11215751
Primary Designation Director
Industry Pharma
First Appointment 26 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Jul 20252025Active

Directorship timeline

Open interactive timeline →
Quinser Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shakuntala Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shakuntala Devi

Shakuntala Devi currently holds 1 directorship: Quinser Pharmaceuticals Private Limited (Director, since 26 Jul 2025).

Shakuntala Devi was first appointed on 26 Jul 2025 as Director at Quinser Pharmaceuticals Private Limited.

The current boards of Shakuntala Devi's companies include Ajay Katare (Quinser Pharmaceuticals Private Limited), Chidanand Umesh Rajmane (Quinser Pharmaceuticals Private Limited), Kiran Sudhakar Pimparkar (Quinser Pharmaceuticals Private Limited), Ramkumar Kooliyadath (Quinser Pharmaceuticals Private Limited), Vishwanath Ananda Patil (Quinser Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available